• HOME
  • SIGN UP
  • LOGIN
  • KALC

대한폐암학회

D-98 Today 2026-08-04

  • SIGN UP
  • LOGIN
  • KALC 2026
    • Invitation
    • Overview
    • Committee
    • Venue
    • News & Notice
    • Past KALC
  • PROGRAM
    • Program at a Glance
    • Scientific Program
    • E-poster
    • Invited Faculty
  • SUBMISSION
    • Abstract Submission
    • Presentation Guidelines
    • Awards
  • ATTENDANCE
    • Registration
    • Transportation
    • Accommodation
    • More about Seoul
    • Visa
  • SPONSORSHIP
    • Sponsorship Opportunities
    • Our Sponsors

D-98 Today 2026-08-04

KALC 2025 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2025 LOTTE HOTEL WORLD, SEOUL, KOREA

HOME
  • KALC 2026
    • KALC 2026
    • PROGRAM
    • SUBMISSION
    • ATTENDANCE
    • SPONSORSHIP
    • SIGN UP
  • News & Notice
    • Invitation
    • Overview
    • Committee
    • Venue
    • News & Notice
    • Past KALC
  • Invitation
  • Overview
  • Committee
  • Venue
  • News & Notice
  • Past KALC

News & Notice

[KALC 2026 Vol.11] 사전등록 마감 D-4, 세계적인 석학들을 KALC 2026에서 만나보세요
Writer KALC 2026 Date 2026-08-03 Hits 15

 

 

Next [KALC 2026 Vol.11] 4 Days Left for Regular Registration, Meet Our Legacy Masters at KALC 2026 2026.08.03
Previous [KALC 2026 Vol.10] 11 Days Left for Regular Registration! Join Our Exciting Prize Events 2026.07.27
List

Korean Association for Lung Cancer

#1322, Rosedale Officetel, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, 06367, Korea

E-mail. kalc@lungca.or.kr  Tel. +82-2-741-8540

KALC IC 2026 Secretariat

Program & Abstract

E-mail. scientific.kalcic@lungca.or.kr  T. +82-2-6411-7372

General & Registration

E-mail. kalcic@lungca.or.kr   T. +82-2-6411-7378(General), 7319(Registration)

Copyright © Korean Association for Lung Cancer. All Rights Reserved.

사전등록 양식을 작성하는 모습

26년도 대한폐암학회 연회비를 납부하셔야 회원가로 등록이 가능합니다. 연회비 납부하시겠습니까?

회비 납부하기 비회원으로 등록하기

Session IV (A)
Oral Presentation 1

  • September 10 (Thu), 14:45-15:45
  • Room A (Crystal Ballroom 3, 3F)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0047 14:45-14:55 Lung Cancer Screening in Korean Women Who Have Never Smoked with a Family History of Lung Cancer: The NIKE Study So Yeon (lydia) Kim Samsung Medical Center Korea
A-0106 14:55-15:05 Beyond Solid Size: Favorable Prognostic Value of Ground-Glass Opacity in Stage IA Lung Adenocarcinoma Sung Goo Park Samsung Medical Center Korea
A-0212 15:05-15:15 Cardio-Oncology Clinic Involvement and Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Receiving Targeted Therapy Hyukjin Park Chonnam National Univ. Korea
A-0183 15:15-15:25 Real-World Outcomes of Neoadjuvant Immunotherapy versus Definitive Chemoradiotherapy with Durvalumab Consolidation in Stage III Non-Small Cell Lung Cancer Hye In Lee Seoul National Univ. Korea
A-0091 15:25-15:35 Interim Analysis of Camrelizumab Plus Pemetrexed and Carboplatin in Advanced Non-Squamous NSCLC Juwhan Choi Korea Univ. Korea
A-0017 15:35-15:45 Autologous Vax-NK Consolidation Therapy in ES-SCLC: Identification of Predictive Biomarkers via High-Dimensional Circulating Immune Cell Profiling Sung-Woo Lee Chonnam National Univ. Korea

Session V (A)
Oral Presentation 2

  • September 10 (Fri), 09:10-10:10
  • Room A (Crystal Ballroom 3, 3F)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0207 09:10-09:20 Patient-Specific Lung Cancer Tumoroids for Studying Tumor-Stroma-Immune Interactions and Personalized Immuno-Oncology Yoo Ri Ko Asan Medical Center Korea
A-0118 09:20-09:30 Unbiased Transcriptome-Derived AI Classification of Tertiary Lymphoid Structures on H&E Images Predicts Survival and Immune Microenvironment in NSCLC Jaeyoon Lee Northwestern Univ. Korea
A-0097 09:30-09:40 Prognostic Impact of Spread Through Air Spaces and Optimal Surgical Extent in Stage I NSCLC after Sublobar Resection Sangil Yun Seoul National Univ. Korea
A-0134 09:40-09:50 Phenotype-Dependent Nonlinear Associations Between Tumor Size and Aggressive Histologic Features in Lung Adenocarcinoma Hyojin Kim Seoul National Univ. Korea
A-0100 09:50-10:00 Beyond Major Pathological Response: Favorable Pathological Response Improves Risk Stratification After Neoadjuvant Chemoimmunotherapy for Resectable NSCLC Hsiang Teng Tri-Service General Hospital Taiwan
A-0057 10:00-10:10 Pathologic Response in Lymph Nodes after Neoadjuvant Therapy in NSCLC: Tumor Bed Extent, Not VT%, Drives Survival Associations Sungjin Kim Seoul National Univ. Korea

Basic & Translational Research / Biology / Pathology

Basic & Translational Research / Biology / Pathology
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0033 PE1-01 Designing Novel Therapy for Lung Cancer using Monobody Scaffolds Targeting EGFR Tushar Kushwaha All India Institute Of Medical Sciences India
A-0056 PE1-02 Mutational Profiling and Network Analysis of Circulating Cell-Free DNA in Chemical Carcinogen-Induced Murine Lung Cancer Models Saumya Patel Gujarat University India
A-0088 PE1-03 Optimizing Intraoperative STAS Prediction in Stage IA Lung Adenocarcinoma: Composite Rule Integrating Frozen and CT Findings Yeon Bi Han Seoul National University Bundang Hospital Korea
A-0132 PE1-04 Inflammation Meets Matrix Remodeling: NF-kB and MMP-3 Signatures in COPD-Associated Lung Carcinogenesis Isura Febrihartati University of Lampung Indonesia
A-0028 PE1-05 DNA Methylation Evaluation in Blood-Derived Cell-Free DNA as an Approach to Identify Biomarkers for the Early-Stage Lung Cancer Diagnosis Deep Raj Yadav King George's Medical University India
A-0063 PE1-06 Translational Evaluation of 2 beta-Hydroxybetulinic Acid 3-Oleiate Against EGFR/KRAS-Driven Redox-Metabolic Vulnerabilities in Non-Small Cell Lung Cancer Danish Ahmed Sam Higginbottom University Of Agriculture, Technology And Sciences India
A-0060 PE1-07 Restoring Mitochondrial Apoptosis in Non-Small Cell Lung Cancer Through Pharmacoinformatic Modulation of the STAT3/MCL-1 Axis Rizki Rachmad Saputra Universitas Palangka Raya Indonesia
A-0067 PE1-08 Transcriptomic Analysis of Glycyrrhiza glabra (Licorice) Derived microRNAs and Their Cross-Kingdom Regulatory Potential in Lung Carcinoma Mitsu Patel Gujarat University India
A-0074 PE1-09 Aloesin inhibits lung cancer metastasis, apoptosis and proliferation by modulating the JAK/STAT3 signaling pathway N Singh Csvtu, Bhilai India
A-0073 PE1-10 Curcumin-Loaded Hybrid Polymeric Nanoparticles Inhibit Diethylnitrosamine (DEN) and 2-acetylaminofluorene -Induced Lung Carcinogenesis via Modulation of EGFR and Apoptosis Deepika Singh Shuats India
A-0071 PE1-11 Revesterol Encapsulated Solid Lipid Nanoparticles Inhibit the Diethylnitrosamine/2-Acetylaminofluorene Induced Lung Cancer by modulating Apoptosis and Suppressing Proliferation Deepika Singh Shuats India
A-0069 PE1-12 Application of Machine Learning and Artificial Intelligence for Prediction of Lung Cancer Risk in Central India Manvendra Singh Hmfa Miet India
A-0078 PE1-13 Efficacy Evaluation of Circulating Tumor Cells Enrichment Platforms in Advanced Lung Cancer: A Pilot Study Jae Heun Chung Pusan National University Yangsan Hospital Korea
A-0081 PE1-14 Development of an Orthotopic Mouse Model for Spread Through Air Space in EGFR E19del NSCLC with Gefitinib Resistance Sungjin Kim Seoul National University Bundang Hospital Korea
A-0144 PE1-15 Engineered PterostilbeneChitosan Nanoparticles Combat Benzopyrene-Induced Lung Cancer through Alteration of HO-1/Nrf2 Signaling Pathway D Chauhan Rajkamal Science & Management College India
A-0140 PE1-16 Umbelliferone-Chitosan nanobeads ameliorate Diethylnitrosamine induced Lung Carcinogenesis in rats via alteration of Nrf-2/HO-1 and PI3K/AKT/NF-B signaling pathway V Kumar Shalom Institute Of Health & Allied Sciences India
A-0128 PE1-17 Ganoderic Acid-Chitosan Lipid Nanoparticles Attenuate Benzopyrene-Induced Lung Cancer via Alteration of PI3K/Akt/mTOR, NF-B and MAPK/ERK Signaling Pathway Vikas Kumar Sam Higginbottom University Of Agriculture, Technology & Sciences India
A-0127 PE1-18 Clinicopathologic correlates of TTF-1 expression pattern in differentiated lung adenocarcinoma Heae Surng Park Ewha Womans University Medical Center Korea
A-0125 PE1-19 Transcriptomic Deconvolution of Non-Small Cell Lung Cancer Resection Margins Identifies a 5-Gene Signature Predicting Post-Lobectomy Recurrence Hafsa Riaz Islamic University Of Indonesia Pakistan
A-0123 PE1-20 Patient-Derived Organoids Reveal Tumor Heterogeneity and Plasticity Underlying Drug Resistance in Lung Squamous Cell Carcinoma Ji Eun Park Gwangju Institute of Science and Technology Korea
A-0122 PE1-21 Comparative Analysis of Bronchoalveolar Lavage Fluid-Derived Exosomal microRNA Profiles between Early-Stage and Advanced-Stage Non-Small Cell Lung Cancer Hyerin Kang Dongtan Sacred Heart Hospital Korea
A-0165 PE1-22 Coexisting ALK Rearrangement, EGFR L858R Mutation, and Germline BRIP1 Variant in Lung Adenocarcinoma With Durable Response to Alectinib Priscillia Imelda Dharmais Cancer Hospital, National Cancer Center, Indonesia Indonesia
A-0163 PE1-23 Claudin 18.2 as a Specific Diagnostic Marker for Pulmonary Invasive Mucinous Adenocarcinoma Jungsup Byun Daegu Fatima Hospital Korea
A-0167 PE1-24 Targeting the PARP1/SRC Axis Associated with DNA Repair and Metastatic Progression in NSCLC: Pharmacoinformatic Study of Xylaria sp. Metabolites Rizki Rachmad Saputra Universitas Palangka Raya Indonesia
A-0174 PE1-25 Quercetin and Vitexin as Multi-Target Inhibitors of KRAS, ALK, and BRAF in NSCLC Kajal Arora Galgotias University India
A-0179 PE1-26 Integrated Bioinformatics Analysis For Identification Of Key Metabolic Hub Genes In Lung Cancer Sahil Arora Sharda University India
A-0192 PE1-27 Platelet Indices as Prognostic Biomarkers in Lung Cancer: An Updated Systematic Review and Dose Response Meta-analysis Ahmed Almezaine Ministry of Health Egypt
A-0186 PE1-28 Differences in the Risk Association of TERT rs2736098 with Lung Cancer Between Two Ethnic People from Different Ancestry: A Meta-Analysis Farhana Sultana Mitu Islamic University Bangladesh
A-0185 PE1-29 A Meta-Analytic Approach to Identify the Association Between p73 rs2273953 to rs1801173 Polymorphism and Risk of Lung Cancer Md Abdullah Al Maruf Islamic University Bangladesh
A-0182 PE1-30 SUMOylation-Mediated SHMT2 Degradation by WYC209 Reverses Osimertinib Resistance through Serine-Glycine Pathway Disruption in Lung Cancer Jiaxuan Xu Nanjing University of Chinese Medicine China
A-0209 PE1-31 CTSC promotes malignant phenotypes and maintains autophagy-related machinery through a YAP-dependent ATG5/ATG7 axis in small cell lung cancer Nayoung Kim Chungnam National University Korea

Big Data & AI

Big Data & AI
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0050 PE1-32 Extended CT Surveillance Beyond 5 Years and Outcomes in Long-term Lung Cancer Survivors Dong Woog Yoon Samsung Medical Center Korea
A-0098 PE1-33 Predicting Lung Cancer Risk Using Machine Learning Models on an Open Clinical Dataset: A Comparative Study Lambe Teddy Pokoknya Ada Medical Research Institute Indonesia
A-0171 PE1-34 Impact of Metabolic Syndrome on Risk of Lung Cancer Among Korean Never-Smokers: A Nationwide Population-Based Cohort Study Dongwon Park Shihwa Medical Center Korea
A-0014 PE1-35 Circulating Small Extracellular Vesicle miRNAs as Diagnostic Biomarkers for NSCLC: A Sequencing and Validation Study Kamal Baswal Aiims New Delhi India
A-0086 PE1-36 Automated RECIST-Guided Longitudinal Lesion Tracking on a Per-Timepoint Annotated Thoracic CT Cohort: A Pilot Study Jin Lee Chonnam National University Korea

Others

Others
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0187 PE1-37 Platelet Indices as Prognostic Biomarkers in Lung Cancer: A Meta-Analysis Md Abdullah Al Maruf Islamic University Bangladesh
A-0026 PE1-38 A Rare Case Report: Type III Pleuropulmonary Blastoma in a Child with DICER1 Syndrome Chew Way Jin University Malaya Medical Center (PPUM) Malaysia

Pulmonology / Endoscopy

Pulmonology / Endoscopy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0087 PE1-39 Better Clot Prevention, Greater Bleeding Risk? Optimizing Cancer-Associated Thromboprophylaxis with DOACs Versus LMWH: A Systematic Review and Meta-Analysis Lutfi Hafiz Zunardi Sunan Kalijaga General Hospital Indonesia
A-0154 PE1-40 Intratumoral Cisplatin For Primary And Metastatic Lung Tumors: A Systematic Review Vince Nigel Blanco St. Luke's Medical Center Philippines

Radiology / Staging / Screening / Epidemiology

Radiology / Staging / Screening / Epidemiology
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0200 PE1-41 Discontinuation of Lung Cancer Clinical Studies: A Cross-Sectional Analysis Yousef Radwan Alnomani Faculty Of Medicine, Benha University Egypt
A-0221 PE1-42 Provincial Burden of Lung Cancer Mortality Attributable to Active and Secondhand Smoking Across Indonesia Zulfania Rahmah Al Aziz Hospital Indonesia
A-0220 PE1-43 Three Decades of Lung Cancer DALYs in Southeast Asia: Temporal Trends and Geographic Variation Nazala Safira Universitas Islam Indonesia Indonesia
A-0206 PE1-44 Spatial Distribution of Lung Cancer Disability-Adjusted Life Years and Associated Risk Factors Among Adults Aged 2054 Years in Indonesia Nazala Safira Universitas Islam Indonesia Indonesia
A-0034 PE1-45 Diagnostic Test of an Integrated Immuno-Nutritional Scoring System (INSS) to Differentiate Lung Cancer from Pulmonary Tuberculosis in Resource-Limited Settings Muhamad Ramdani Ibnu Taufik Cakra Husada Hospital Indonesia
A-0052 PE1-46 Clinical and Epidemiologic Profile and Predictors of Advanced-Stage Disease Among Filipino Female Never-Smokers with Lung Adenocarcinoma: An Analytical Cross-Sectional Study Vince Nigel Blanco St. Luke's Medical Center Philippines
A-0068 PE1-47 Development of a Loop-Mediated Isothermal Amplification Assay for EML4-ALK Variant 1 Detection Ferdinand Mira Ateneo De Manila University Philippines
A-0099 PE1-48 Association Between Household Cooking Fuel Type and Chronic Respiratory Symptoms Among Never-Smoking Indonesian Adults Lambe Teddy Pokoknya Ada Medical Research Institute Indonesia
A-0130 PE1-49 Public Acceptability of Expanding National Lung Cancer Screening Eligibility in South Korea: A Nationwide Survey Jegu Kang National Cancer Center Korea
A-0121 PE1-50 Impact of an Artificial Intelligence Integrated Computer Aided Quality Control System on Screening Accuracy in Korean National Lung Cancer Screening Ji-Youn Song National Cancer Center Korea
A-0119 PE1-51 Participation Rates and Screening Outcomes of the National Organized Population- Based Lung Cancer Screening Program in Korea National Cancer Center Korea
A-0153 PE1-52 Regional Variations in Young-Onset Lung Cancer Burden Across Java Island: Insights from Five-Year Global Burden of Disease Analysis Cindy Ayudia Pramaesti Kustati Hospital Indonesia
A-0172 PE1-53 Trends in the Burden of Tracheal, Bronchus, and Lung Cancer in Indonesia, 1990 to 2023: Insights From GBD 2023 Adi Nugraha Rsui Banyubening Boyolali Indonesia
A-0198 PE1-54 Development and Validation of a Prognostic Model for Lung Cancer-Specific Survival Following Surgical Resection: A Population-Based study Ahmed Ghait Ministry of Health Egypt
A-0193 PE1-55 Racial and Ethnic Disparities in Surgical Management of Early-Stage Non-Small Cell Lung Cancer: A Population Based Study Ahmed Almezaine Ministry of Health Egypt
A-0217 PE1-56 Artificial Intelligence for CT-Based Pulmonary Nodule Detection and Lung Cancer Risk Stratification Maha Fatima National Cancer Center Korea
A-0204 PE1-57 Association Between Dietary Inflammatory Index and Lung Cancer Risk: A Systematic Review and Meta-Analysis Amir Hegazi Mansoura University Egypt

Early / Locally Advanced Non-Small Cell Lung Cancer

Early / Locally Advanced Non-Small Cell Lung Cancer
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0008 PE2-01 First-Line Afatinib in Uncommon EGFR-Mutant Stage IV NSCLC: Real-World Outcomes Anh Nguyen Hanoi Medical University Vietnam
A-0037 PE2-02 Clinical Outcomes and Pathological Characteristics of Surgically Resected EGFR-mutant Non-small Cell Lung Cancer According to the Consolidation-to-tumor Ratio: Case-control Study Taehun Kim Keimyung University Dongsan Medical Center Korea
A-0158 PE2-03 Resistance Mechanisms and Secondary Mutations Following Third-Generation EGFR Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-Analysis Nabila Nurisma Faculty of Medicine Universitas Indonesia Indonesia
A-0162 PE2-04 Chemo-immunotherapy and Surgical Completion in Resectable Non-Small Cell Lung Carcinoma: A TriNetX Study of 11,572 Matched Patients Ahmed Elaraby Al-Azhar University Egypt
A-0009 PE2-05 Real-World Survival Outcomes of Afatinib in Advanced NSCLC Patients with Major Uncommon EGFR Mutations: A Subgroup Analysis of G719X Anh Nguyen Hanoi Medical University Vietnam
A-0051 PE2-06 Brain Metastases After Lung Adenocarcinoma Surgery: Safer with Neoadjuvant or Adjuvant Chemotherapy? A Nationwide Registry Analysis Nisrina Nabila Universitas Islam Indonesia Indonesia
A-0077 PE2-07 Treatment Preferences for Stage II NSCLC in Korea: A Cross-Sectional Survey on Upfront Surgery versus Neoadjuvant Therapy Jiwon Kwak Samsung Medical Center Korea
A-0085 PE2-08 High Level of Preoperative NK Cell Activity Predicts Delay of Recurrence in Surgically Resected Lung Cancer Seung Hyeun Lee Kyung Hee University Korea
A-0105 PE2-09 Divergent EMT Regulation in the Tumor-Adjacent Microenvironment Drives Prognostic Divergence in GGO and Solid Lung Adenocarcinoma Han Sanghyun Chungbuk National University Korea
A-0101 PE2-10 Sequential Targeted Therapy and Immunotherapy in NSCLC: A FAERS Analysis Reveals Increased Risk of Severe and Fatal Pneumonitis Ekram Hasanin University of Tripoli Libyan Arab Jamahiriya

Mesothelioma / Thymic & Other Thoracic Malignancies

Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0146 PE2-11 Surgical Resection of Residual Mediastinal Masses After Induction Chemotherapy for Primary Mediastinal Non-Seminomatous Germ Cell Tumors Parvin Akhmedov The Loginov Moscow Clinical Scientific Center Russian Federation
A-0156 PE2-12 Integrative Bioinformatic Analysis of Personalized Malignant Suppression with Deoxypodophyllotoxin in Pleural Mesothelioma Patients Anindya Amanda Damayanti Medaeng Public Health Center Indonesia
A-0219 PE2-13 The Only High-Income Country With a Rising Mesothelioma Trend: A Nationwide Prospective Cohort Study From South Korea Kwanyong Hyun The Catholic University of Korea St. Vincent's Hospital Korea
A-0191 PE2-14 Turning Clinical Challenges into Treatment Opportunities: The Role of MDT in Mediastinal Solitary Fibrous Tumour Chan Teng Chong National Cancer Institute Malaysia

Radiotherapy

Radiotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0082 PE2-15 Beyond Conventional Dosimetric Indices: A Plan Quality Index Based Evaluation of IMRT, VMAT and Hybrid Plans in NSCLC Shreyasee Karmakar Mgm New Bombay Hospital India
A-0080 PE2-16 Outcomes of Lung Stereotactic Body Radiation Therapy for Pulmonary Metastases from Uncommon Primary Malignancies: An Early Institutional Experience Akshay Mangaj Mpct Hospital India
A-0147 PE2-17 Associations of Chemotherapy and Radiotherapy With Mortality in Lung Cancer: A Population-Based SEER Study Zavia Putri Salsabila Islamic Weleri Hospital Indonesia
A-0038 PE2-18 Optimal Integration of SRS and Next-Generation TKIs for Brain Metastatic in Driver Mutant NSCLC: A Matched Case-Series Keh Yee Tan Sabah Women & Children Hospital Malaysia
A-0199 PE2-19 Prophylactic Cranial Irradiation in the Immunotherapy Era for Extensive-Stage Small Cell Lung Cancer: An Systematic Review and Meta-analysis Mohamed Hegazy Ministry of Health Egypt
A-0184 PE2-20 Association of Targeted Therapy with Outcomes after LINAC-based Radiosurgery for Lung Cancer Brain Metastases Yen-Ting Liu National Taiwan University Taiwan

Surgery

Surgery
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0023 PE2-21 Surgical Strategy in Patients with Concomitant NonSmall Cell Lung Cancer and Valvular Heart Disease Dam Hai Son E Hospital Vietnam
A-0197 PE2-22 Risk Factors and Mortality Associated with Postoperative Pneumonia Following Lung Cancer Resection: An Systematic Review and Meta-analysis Ahmed Ghait Ministry of Health Egypt

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0027 PE3-01 Osimertinib in Advanced Non-Small Cell Lung Cancer with Uncommon or Compound EGFR Mutations: A Retrospective Study Trung Nguyen Vietnam National Cancer Hospital Vietnam
A-0032 PE3-02 Beyond Trial Eligibility: Real-World Tolerability and Treatment Persistence of EGFR TKIs in Older Patients With EGFR-Mutated NSCLC Noor Nabila Binti Mohamad National Cancer Institute Malaysia
A-0044 PE3-03 Perioperative Chemotherapy and Mortality Among Surgically Treated Lung Cancer Patients: A SEER Cohort Study Zavia Putri Salsabila Universitas Islam Indonesia Indonesia
A-0043 PE3-04 Treatment Patterns and Temporal Trends in Resectable Clinical Stage II NSCLC: A Single-Center Real-World Analysis Dong Woog Yoon Samsung Medical Center Korea
A-0042 PE3-05 Efficacy and Safety of HER2-Directed Tyrosine Kinase Inhibitors in Advanced HER2-Mutant NonSmall-Cell Lung Cancer: A Meta-Analysis Noha Hammad Port Said University Egypt
A-0065 PE3-06 First-Line Pembrolizumab with or without Chemotherapy in Metastatic Non-Small Cell Lung Cancer with Non-EGFR/ALK Driver Mutations: A Real-World Study Minh Truong Vietnam National Cancer Hospital Vietnam
A-0079 PE3-07 STAT5A/B Mediated TH Differentiation and Immune Modulation in Non-Small Cell Lung Cancer Roshni Bibi SRM Institute of Science and Technology India
A-0148 PE3-08 Integrative Bioinformatic Optimization of Personalized Anti-Cancer Drug Targeting Microtubule Depolymerization to Prevent Non-Small Cell Lung Cancer Metastasis Anindya Amanda Damayanti Medaeng Public Health Center Indonesia
A-0145 PE3-09 Conversion Surgery Following Pembrolizumab-Based Chemoimmunotherapy in cT3N2M1 Oligometastatic Non-Small Cell Lung Cancer: Two Cases of Pathologic Complete Response Parvin Akhmedov The Loginov Moscow Clinical Scientific Center Russian Federation
A-0142 PE3-10 Natural Products Targeting the Tumor Immune Microenvironment in Lung Cancer: A Bibliometric Analysis Valentina Aguilera Universitas Palangka Raya Indonesia
A-0138 PE3-11 Systemic Inflammatory Biomarkers Predict Survival Outcomes in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Zulfania Rahmah Islamic Indonesia University Indonesia
A-0133 PE3-12 Age Related Molecular Heterogeneity of EGFR Mutated Lung Adenocarcinoma: Differential Distribution of Exon 19 Deletion and L858R Mutations Isura Febrihartati University of Lampung Indonesia
A-0166 PE3-13 Circulating MicroRNAs as Non-Invasive Biomarkers for EGFR-Mutated Lung Adenocarcinoma: A Meta-Analysis Cha Jin Hee University of Indonesia Indonesia
A-0178 PE3-14 Circulating MicroRNAs Associated with PD-L1 Expression in Non-Small-Cell Lung Cancer: A Systematic Review Cha Jin Hee University of Indonesia Indonesia
A-0176 PE3-15 Biological Potential Of Engeletin On Apoptotic Cell Death In Lung Cancer Cells And Xenograft Tumors Derived From Cell Lines Dinesh Kumar Patel Sam Higginbottom University of Agriculture India
A-0218 PE3-16 Sarcopenia as a Prognostic Marker in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis Rashad Mohamed Mansoura University Egypt
A-0018 PE3-17 Synchronous Non-Small Cell Lung Cancer with KRAS G12C Mutation and Hepatocellular Carcinoma: A Case Report and Therapeutic Challenges Thao Nguyen Hanoi Medical University Hospital Vietnam
A-0021 PE3-18 KRAS Beyond Boundaries: Unusual Subcutaneous Chest Wall Metastases in KRAS-Mutant Non-Small Cell Lung Cancer - A Five-Case Series Thao Nguyen Hanoi Medical University Hospital Vietnam
A-0031 PE3-19 Predicting the Silent Threat: Risk Stratification for Acute Renal and Hepatic Dysfunction in Lung Cancer Chemotherapy Muhamad Ramdani Ibnu Taufik Cakra Husada Hospital Indonesia
A-0046 PE3-20 Durable Survival Despite Substantial CNS Disease Burden in Metastatic ALK-positive NSCLC: Real-World Outcomes from a Malaysian Cohort. Izzati Rosli National Cancer Institute Putrajaya Malaysia Malaysia
A-0107 PE3-21 Cardiovascular Burden Associated with Immuno-oncology Agents in Lung Cancer: A Systematic Review and Meta-Analysis Elen Putri Cintya Universitas Brawijaya Indonesia
A-0149 PE3-22 Targeting Epithelial-Mesenchymal Transition and Drug Resistance Through YAP1 and AXL Gene Silencing in NSCLC: A Bioinformatics Approach Rian Ka Praja Universitas Palangka Raya Indonesia
A-0139 PE3-23 Unmasking a Rare EGFR Exon 18 Mutation Through Repeat Molecular Profiling in Initially Mutation-Negative Metastatic NSCLC: A Case Report Neshreen Kingking St.luke's Medical Center Philippines
A-0137 PE3-24 Cortisol-ACTH Axis Patterns and Immunotherapy Outcomes in Lung Cancer: A Single-Center Retrospective Cohort Study Da Hyun Kang Chungnam National University Hospital Korea
A-0115 PE3-25 Cycle-to-Cycle ANC Stability Independently Predicts Survival in Heavily Pretreated Advanced NSCLC Receiving Metronomic Weekly Paclitaxel Green Hong Chungnam National University Hospital Korea
A-0170 PE3-26 Real-World Efficacy and Safety of Pemetrexed-Platinum Chemotherapy with or without Bevacizumab in Advanced EGFR-Mutant NSCLC after TKI Failure Vuong Nghiem Tran Danang Oncology Hospital Vietnam
A-0190 PE3-27 Determinants of Therapeutic Response and Survival Outcomes Following EGFR-TKI Therapy in Metastatic EGFR-Mutant NSCLC Jatinkumar Veljibhai Dhanani Gmers Medical College India
A-0225 PE3-28 Efficacy and Safety of Third-Generation EGFR-TKI Combinations versus Monotherapy as First-Line Treatment for EGFR-Mutated Advanced NSCLC: A Bayesian Network Meta-Analysis I Gede Aswin Parisya Sasmana Udayana University Indonesia
A-0214 PE3-29 Second vs Third-Generation EGFR-TKIs as Frontline Treatment for EGFR-Mutant NSCLC: Interim Results from Korean EGFR Registry Seung Hyeun Lee Kyung Hee University Medical Center Korea

Palliative Care

Palliative Care
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0048 PE3-30 Deletion of SASP Cardiomyocytes with Senolytic Drugs Conferred Therapeutic Effects in ICIs-Related Cardiotoxicity Meng Hou Shanghai Pulmonary Hospital China
A-0062 PE3-31 Emerging Psychotherapy to Support Coping Among Patients with Lung Cancer: A Scoping Review (20202026) Siti Makhmudah Universitas Gadjah Mada Indonesia
A-0136 PE3-32 Digital and Telehealth-Based Palliative Care Interventions for Patients with Advanced Lung Cancer: A Systematic Review of Patient-Centered Outcomes Nazala Safira Universitas Islam Indonesia Indonesia

Small Cell Lung Cancer / Neuroendocrine Tumors

Small Cell Lung Cancer / Neuroendocrine Tumors
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0108 PE3-33 Integrated Transcriptomic Identification of Prognostic Neuroendocrine Drivers and Immune Landscape Alterations in Small Cell Lung Cancer Muhammad Hamza Mubarak Universitas Islam Indonesia Pakistan
A-0045 PE3-34 Integrated Transcriptomic Analysis Reveals Neuroendocrine and Cell-Cycle Signatures in Small Cell Lung Cancer Vica Hilda Amelia Universitas Islam Indonesia Indonesia
A-0064 PE3-35 Real-World Pilot Experience of Consolidative Thoracic Radiotherapy with Chemo-Immunotherapy in ES-SCLC: Efficacy and a Key Pulmonary Safety Signal Jae Heun Chung Pusan National University Yangsan Hospital Korea
A-0072 PE3-36 DLL3-based Enrichment Enables Sensitive and Specific Detection of Circulating Tumor Cells During Immunotherapy in Extensive Stage Small-cell Lung Cancer Hyung-Joo Oh Chonnam National University Hwasun Hospital Korea
A-0090 PE3-37 Artificial Intelligence-Based Endothelial Cell Profiling Reveals a Prognostic Signature in the Tumor Microenvironment of Small-Cell Lung Cancer Wonseok Choi Korea University Guro Hospital Korea
A-0095 PE3-38 Clinical Impact and Prognostic Factors of Early Radiotherapy in Limited-Disease Small-Cell Lung Cancer: A Cohort Study Kyung-Il Han Hanyang University Guri Hospital Korea
A-0109 PE3-39 Prophylactic Cranial Irradiation and Survival Outcomes in Treatment Responders with Limited-Stage Small Cell Lung Cancer After Thoracic Radiotherapy Ye Won Kim Keimyung University Dongsan Medical Center Korea
A-0168 PE3-40 The Potential Kemukus (Piper cubeba L.) as Anticancer Agents: An In Silico Study of Activity and and Molecular Interactions Decenly Decenly Universitas Palangka Raya Indonesia
A-0196 PE3-41 Epidemiology and Survival Outcomes of Pulmonary Large Cell Neuroendocrine Carcinoma: A Population-Based Study Abdelrahman Hatata Ministry of Health Egypt